Avian Influenza A(H5N1) outbreak reported in Cambodia
On Sep. 2, 2024, the World Health Organization (WHO) confirmed that a laboratory-confirmed case of human infection with…
-
-
Novavax Formula COVID-19 Vaccine Authorized and Recommended for Use in the U.S.
On Aug. 30, 2024, Novavax announced the Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) (NVX-CoV2705) had received Emergency Use…
-
Biotechnology | Polio | Vaccine | WHO
UN to vaccinate Gaza’s children against polio during pauses in fighting
On Aug. 30, 2024, the United Nations (UN) announced that polio vaccination will begin for some 640,000 children…
-
Biotechnology | Disease | Infectious Disease | NIH | Non-Profit Research | Pharmaceutical | Therapeutics | Vaccine
Emergent BioSolutions’ ACAM2000® Received U.S. FDA Approval for Mpox Indication
On Aug. 29, 2024, Emergent BioSolutions announced that the U.S. Food and Drug Administration (FDA) had approved the supplemental Biologics…
-
Vaccine Misinformation caused U.S. Covid-19 Vaccination rate to Drop
On Aug. 28, 2024, with the nation in the midst of a summer surge of Covid-19 infections and…
-
New Hampshire reported fatality from Eastern Equine Encephalitis Virus
On Aug. 27, 2024, the New Hampshire Department of Health and Human Services (DHHS) announced they have identified…
-
Global strategic preparedness and response plan launched by WHO to contain mpox outbreak
On Aug. 26, 2024, the World Health Organization (WHO) launched a global Strategic Preparedness and Response Plan to…
-
The CDC reported Two more variant flu cases from swine exposure in Ohio and Pennsylvania
On Aug. 23, 2024, the U.S. Centers for Disease Control and Prevention (CDC) reported that two human infections…
-
Pfizer and BioNTech Received U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vaccine
On Aug. 22, 2024, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) had approved…
-
Biotechnology | Disease | Medicine | Vaccine | WHO
Outbreak of Oropouche virus disease reported in South America
On Aug. 23, 2024, the World Health Organization (WHO) reported an outbreak of Oropouche virus (OROV) in the…
-
Study during DR Congo’s outbreak found 84% protection from Ebola vaccine
On Aug. 21, 2024, French and Democratic Republic of the Congo (DRC) researchers announced that a real-world study…
-
CPRIT awarded more than $60 million to boost fight against cancer
On Aug. 21, 2024, the governing body of the Cancer Prevention and Research Institute of Texas (CPRIT) approved…
-
New insights on how bird flu crosses the species barrier
On Aug. 19, 2024, scientists at the European Molecular Biology Laboratory (EMBL) published research that sheds light on…
-
ECDC recommended enhancing preparedness as more imported cases of clade I mpox highly likely
On Aug. 16, 2024, the European Centre for Disease Prevention and Control (ECDC) has said that it is…
-
Western university announced newly discovered protein stops dNA damage
On Aug. 15, 2024, researchers from from Western University announced they had discovered a protein that has the…
-
Biotechnology | Disease | Infectious Disease | Medicine | Vaccine | WHO
WHO declared mpox outbreak a public health emergency of international concern
On Aug. 14, 2024, The World Health Organization declared that the upsurge of mpox in the Democratic Republic…
-
Artificial Intelligence | Biotechnology | CRISPR | Genomics | Life Science History | Medicine | NIH | Non-Profit Research | Therapeutics | Vaccine
Biden announced $150 million in research grants as part of his ‘moonshot’ push to fight cancer
On Aug. 13, 2024, President Joe Biden is zeroing in on the policy goals closest to his heart…
-
University of Houston Researchers Created New Treatment and Vaccine for Flu and Various Coronaviruses
On Aug. 6, 2024, a team of researchers, led by the University of Houston, announced they had discovered…
-
BioNTech sued by UPenn over COVID-19 vaccine patent royalties
On Aug. 6, 2024, the University of Pennsylvania announced it had sued German biotechnology firm BioNTech n Pennsylvania…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Vaccine | WHO
WHO/Europe study confirmed lifesaving impact of vaccines against COVID-19 Summer Wave
On Aug. 2, 2024, the World Health Organization (WHO) announced results of a study that showed the introduction…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Influenza | Plague | Vaccine | WHO
CEPI and WHO urge broader research strategy for countries to prepare for the next pandemic
On Aug. 1, 2024, the Coalition for Epidemic Preparedness Innovations (CEPI) and the World Health Organization (WHO) called…
-
Biotechnology | Influenza | Vaccine | WHO
New initiative launched to advance mRNA vaccine development against human avian influenza (H5N1)
On Jul. 29, 2024, a new project that aims to accelerate the development and accessibility of human avian…
-
Fatal H5N6 avian flu case reported in China
On Jul. 25, 2024, The Centre for Health Protection (CHP) of the Department of Health in Hong Kong…
-
Biotechnology | Diagnostics | Infectious Disease | Influenza | USDA | Vaccine | Veterinary
Cornell Study confirmed mammal-to-mammal avian flu spread
On Jul. 24, 2024, a team led by researchers at Cornell University announced a study that provides evidence…
-
HPAI clade 2.3.4.4b A(H5N5) virus spillover into North America mammals increasing
On Jul. 23, 2024, a study published in Cell Reports revealed that seabirds likely facilitated the spread of…
-
SIGA announced U.S. Government procurement orders of approximately $138 million for oral and IV TPOXX
On Jul. 19, 2024, SIGA Technologies announced that the U.S. Department of Health and Human Services exercised procurement…
-
Sabin Vaccine Institute Delivered Marburg Vaccines to Combat Outbreak in Rwanda
On Jul. 15, 2024, the Sabin Vaccine Institute launched a Phase 2 clinical trial for its vaccine against…
-
Biotechnology | CDC | COVID-19 | Diagnostics | FDA | Infectious Disease | Vaccine | Women's Health
Late-pregnancy RSV vaccination not associated with poor birth outcomes
On Jul. 8, 2024, a study reported that babies exposed to maternal RSV (respiratory syncytial virus) vaccination in…
-
Emergent BioSolutions Awarded $250+ Million in Contract to Supply U.S. Government with Four Critical Medical Countermeasure Products
On Jul. 2, 2024, Emergent BioSolutions announced it had received more than $250 millionin contract modifications from the…
-
Moderna Received $176 million Award through BARDA to Accelerate Development of mRNA-based Pandemic Influenza Vaccine
On Jul. 2, 2024, Moderna announced a project award of $176 million through the Rapid Response Partnership Vehicle…
